Mitre Edson Ibrahim, Figueira Alessandra Sousa, Rocha Aparecida Barbosa, Alves Simone Maria Cordeiro
School of Medical Sciences, Santa Casa de São Paulo, Brazil.
Braz J Otorhinolaryngol. 2006 May-Jun;72(3):350-4. doi: 10.1016/s1808-8694(15)30967-8.
To co-relate the use of hormonal contraceptives with positive Auditory and Vestibular alterations.
medical history taking, audiometric test and vestibular test was applied to 60 women between the ages of 14 and 35 years old, and 30 of these women are on oral hormonal contraceptive consisting of Estrogen and Progesterone (risk group), for 6 months or more, that had no Auditory or Vestibular complaints prior to the usage of hormones; and 30 women that had never used these hormones (control group), with no Auditory or Vestibular complaints. Medical history was used to select the sample.
Based on otoneurological findings, through quantitative research, we could see the prevailing Irritatative Peripheral Vestibular Syndrome and tinnitus in the risk group, without audiometric alterations.
The use of oral contraceptives can provoke functional alterations in the inner ear, specially tinnitus and Irritative Peripheral Vestibular Syndrome in the risk group; but auditory threshold alterations were not evident.
将激素避孕药的使用与听觉和前庭的阳性改变相关联。
对60名年龄在14至35岁之间的女性进行病史采集、听力测试和前庭测试，其中30名女性服用含雌激素和孕激素的口服激素避孕药（风险组）达6个月或更长时间，她们在使用激素之前没有听觉或前庭方面的主诉；另外30名女性从未使用过这些激素（对照组），也没有听觉或前庭方面的主诉。通过病史来选择样本。
基于耳神经学检查结果，通过定量研究，我们发现在风险组中主要存在刺激性外周前庭综合征和耳鸣，听力测试无改变。
口服避孕药的使用可引发内耳的功能改变，特别是在风险组中引发耳鸣和刺激性外周前庭综合征；但听觉阈值改变不明显。
